Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Merck
Dow
AstraZeneca
Medtronic
Johnson and Johnson

Last Updated: December 5, 2019

DrugPatentWatch Database Preview

Drugs in Development Information for Proellex

See Plans and Pricing

« Back to Dashboard

What is the drug development status for Proellex?

Proellex is an investigational drug.

There have been 35 clinical trials for Proellex. The most recent clinical trial was a Phase 2 trial, which was initiated on October 1st 2008.

The most common disease conditions in clinical trials are Myofibroma, Leiomyoma, and Endometriosis. The leading clinical trial sponsors are Repros Therapeutics Inc., Northwestern University, and National Cancer Institute (NCI).

Recent Clinical Trials for Proellex
TitleSponsorPhase
An Extension Study of 12 mg Proellex® (Telapristone Acetate) Administered Orally in the Treatment of Premenopausal Women With Confirmed Symptomatic Uterine FibroidsRepros Therapeutics Inc.Phase 2
Transdermal or Oral Telapristone Acetate in Treating Patients Undergoing MastectomyNational Cancer Institute (NCI)Phase 2
Transdermal or Oral Telapristone Acetate in Treating Patients Undergoing MastectomyNorthwestern UniversityPhase 2

See all Proellex clinical trials

Clinical Trial Summary for Proellex

Top disease conditions for Proellex
Top clinical trial sponsors for Proellex

See all Proellex clinical trials

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Merck
Boehringer Ingelheim
McKinsey
Medtronic
Dow
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.